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A prevalence study of epilepsy in
Hong Kong
Objectives. To examine epidemiological data on epilepsy for the Hong Kong
west region.
Design. Descriptive study.
Setting. Epilepsy clinic, university teaching hospital, Hong Kong.
Patients and methods. The epilepsy clinic of Queen Mary Hospital manages
the majority of adult patients (aged 15 years or older) with chronic seizure disorders
resident in the Hong Kong west area with an adult population of 475 900. All
patients underwent electroencephalography examination and each subject was
independently assessed by two epileptologists for diagnosis and classified
according to the International League Against Epilepsy recommendations.
Results. Seven hundred and thirty-six patients (female, 42.9%; male, 57.1%;
mean age, 40.8 years; standard deviation, 13.6 years) with epilepsy were enrolled
in the study. The prevalence rate of active epilepsy in the population 15 years or
older was estimated at 1.54 per 1000 on 1 January 2002. Two hundred and eighty-
five (38.7%) patients had idiopathic epilepsy syndromes, 100 (13.6%) had
cryptogenic epilepsy, and 285 (38.7%) had a remote symptomatic aetiology.
Seizure type was partial in 408 (55.4%) patients and generalised in 285 (38.7%).
Thirty-one (4.2%) patients had a positive family history. Idiopathic generalised
epilepsy syndromes described as common in the literature, such as juvenile
myoclonic epilepsy and childhood absence epilepsy, were infrequently seen at
0.68% and 0.95% of cases, respectively.
Conclusions. This study provides baseline data for epilepsy service development
and research in Hong Kong. The prevalence rate of active epilepsy in this Chinese,
adult population was low compared with that reported in other developed
countries. Further population-based epidemiological research is indicated to
confirm the prevalence of seizure disorders in this locality.
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Introduction
Epilepsy is a common neurological disorder.1 It is the
most common neurological disease worldwide, and the
second most common neurological disease in the
developed world second to stroke. An estimated 45 to
100 million people worldwide suffer from active epilepsy.2
The prevalence and incidence of epilepsy varies across
countries, however. Epidemiological data are crucial for
physicians and health care administrators planning
management of patients with chronic diseases, such as
epilepsy. We report a clinic-based epidemiological study
of patients with epilepsy, living in the urban locality of
Hong Kong west (HKW).
Methods
Study population
The study population included all current patients of the
epilepsy clinic at Queen Mary Hospital (QMH) on 1 January
2002. The epilepsy clinic at QMH is responsible for
patients with chronic seizure disorders living in the HKW
region, which hosts an adult population (aged 15 years or
older) of 475 900.3 More than 97.8% of this population
are ethnic Chinese. In Hong Kong, about 93.6% of the
general population receive a public (socialised) medical
health service.3 Clinic patients are referred from general
practitioners, private neurologists, accident and emer-
gency departments, and on discharge from in-patient services.
The HKW neurological service has operated a catchment
system for its clinics since 1996. Patients’ demographic
data are screened, and patients residing outside the QMH
clinic catchment area are advised, and referred to the neuro-
logical service nearest their residential address. Thus, on
1 January 2002, the majority of neurological patients seen
at the QMH epilepsy clinic were living in the HKW
region.
Inclusion and exclusion criteria
Patients who were residents of the catchment area and who
had experienced two or more unprovoked seizures were
included in the study. Patients with an uncertain diagnosis,
non-epileptic seizures, those who failed to attend follow-up
for more than 1 year, and those who had moved from the
QMH clinic catchment area were excluded.
Investigation procedures and diagnoses
All patients underwent interictal electroencephalography
(EEG) examination, with both awake and asleep tracings
obtained whenever possible. Four hundred and forty-two
neuroimaging studies (63 computed tomography and 379
magnetic resonance imaging brain scans) were performed
for 372 patients. In selected cases, video-EEG, functional
neuroimaging studies, urine metabolic screening, and
neuropsychological assessment were also completed to reach
a precise diagnosis. All patients and investigation results
were assessed by two epileptologists independently, and then
a consensus diagnosis was reached.
Definitions
Definitions from the International League Against Epilepsy
(ILAE) Commission on Classification and Terminology
and the Commission on Epidemiology and Prognosis were
used.4-6 A prevalent case of active epilepsy was defined as a
person with epilepsy who had experienced at least one
seizure in the previous 5 years, regardless of antiepileptic
drug treatment.7 Of note, cases with epilepsy in remission
requiring no medication were normally seen for regular
follow-up at the epilepsy clinic for at least 5 years. Classi-
fication of seizure type was made according to the revised
International Classification of Epileptic Seizures.4 This
classification is based on seizure description, EEG, and other
available investigation results. Aetiology was defined
according to the epidemiological standards set forth by the
ILAE.6 Idiopathic epilepsy was reserved for patients with
certain partial or generalised epileptic syndromes with
particular clinical characteristics and specific EEG findings.
Remote symptomatic epilepsy referred to epilepsy in the
presence of a static neurological abnormality, a history of
brain insult, cerebrovascular disease, or a disorder asso-
ciated with an increased risk of epilepsy presumed to be
aetiologically related to the patient’s epilepsy. Cryptogenic
epilepsy referred to epilepsy in which no factor associated
with increased risk of seizure could be identified as the
underlying aetiology, and the form of epilepsy was not one
of the specific idiopathic syndromes.7
Statistical analysis
Differences between patients according to epilepsy and
seizure type were assessed by the Student’s t test. Statistical
significance was defined as P<0.05. The Statistical Package
for the Social Sciences (Windows version 11.0; SPSS Inc.,
Chicago, US) was used for statistical analysis.
Results
Seven hundred and thirty-six patients (316 [42.9%] females
and 420 [57.1%] males; age range, 17-88 years; mean age,
40.8 years; standard deviation [SD], 13.6 years) were
included in the study. All had chronic active epilepsy, and
had visited the epilepsy clinic at least once in 2001.
Therefore, the derived prevalence rate of active epilepsy in
the catchment population 15 years or older was 1.54 per
1000 on 1 January 2002. Prevalence rates peaked at the age
of 25 to 30 years and then gradually decreased. The data are
presented graphically in the Fig.
Epilepsy type and aetiology
Two hundred and eighty-five (38.7%) patients had idiopathic
epilepsy syndromes, 100 (13.6%) patients were classified
as cryptogenic cases, and 285 (38.7%) patients had remote
symptomatic epilepsy. Aetiological structural abnormalities
could be identified in 231 (81.1%) patients with remote
symptomatic epilepsy. Causes included arteriovenous mal-
formation (n=14), cavernous angioma (n=6), neuronal migra-
tion disorders (n=12), cerebral infarct (n=40), hippocampal
sclerosis (n=47), and focal cerebral atrophy (n=23).
Fong et al
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Seizure types and epileptic syndromes
Seizure type by sex, epilepsy type, and aetiology by age are
shown in Tables 1 to 3. Seizure type was partial in 408
(55.4%), generalised in 285 (38.7%), and unclassifiable in
43 (5.8%) patients. Generalised tonic-clonic seizures and
partial seizures with secondary generalisation were the most
common seizure types. The Student’s t test showed a signi-
ficant difference between the mean age of patients with
idiopathic epilepsy (36.69 years; SD, 12.89 years), crypto-
genic (38.27 years; SD, 10.25 years), and remote sympto-
matic (42.85 years; SD, 14.26 years) epilepsies (P<0.001).
Family history
Thirty-one (4.2%) patients reported a history of seizure
disorders in parents, siblings, or offspring. Idiopathic
generalised epilepsy occurred in 24 (77.4%) patients with a
family history of epilepsy. Partial seizure occurred in the
remaining seven (22.6%) patients—five (16.1%) with tem-
poral lobe epilepsy, one (3.2%) with frontal lobe epilepsy,
and one (3.2%) with partial epilepsy with variable focus.
Among patients with idiopathic generalised epilepsy, two
patients with juvenile myoclonic epilepsy (JME) and five
patients with childhood absence epilepsy (CAE) were
identified. Detailed assessment of other patients with idio-
pathic generalised epilepsy with generalised tonic-clonic con-
vulsion did not reveal features suggestive of JME or CAE.8
Age at seizure onset
Mean age at the onset of epilepsy was 19.94 years (range,
1-72 years). The mean age at onset for idiopathic, crypto-
genic, and remote symptomatic epilepsy were 18.91 (SD,
11.42), 19.90 (SD, 9.91), and 20.63 (SD, 14.28) years, re-
spectively. There was no statistically significant difference
found between the groups with respect to age at onset.
Discussion
We report an epidemiological study of epilepsy in Hong
Kong, with data derived from an epilepsy clinic serving a
population of 475 900. The age-adjusted average annual
incidence of epilepsy has been variously reported in the litera-
ture as from 28.9 to 53.1 cases per 100 000 population.9-13
Generalised onset seizure represents 39% to 59% of cases,
while partial seizure accounts for 32% to 52%.10,11,13 The
cumulative incidence of epilepsy reported is between
1.3%14 and 3.1%15 up to the age of 80 years, with a bimodal
distribution. The first incidence peak has been noted to
occur before 20 years, while the second peak occurs after
60 years.10 The reported prevalence of epilepsy varies from
2.7 to 41.3 per 1000.10,12,13,16-25 Age-specific prevalence peaks
in varying age-groups in different studies. This is a likely
consequence of methodological differences and socio-
economic constituents of different populations.2
Although population-based and hypothesis-driven
epidemiological studies are preferable,7 conflicting epide-
miological studies in Chinese populations26-29 indicated a
need to review local epidemiological data. Under the current
health care system, the Hospital Authority in Hong Kong
manages more than 93.6% of the population requiring
medical care.3 Further, having actively discharged patients
with neurological disorders not in our catchment area, and
taken referrals from other regional hospitals, the pool of
patients in this study would have represented the vast
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majority of patients with chronic epilepsy residing in the
QMH catchment area. Despite this, a number of cases could
have been missed because in Hong Kong, general practi-
tioners, geriatricians, psychiatrists, and neurosurgeons also
manage patients with seizure disorders. For example, some
cases under the care of geriatricians or neurosurgeons, with
good seizure control may be managed without referral to
our clinic. This may explain the missing second prevalence
peak reported after the age of 60 years elsewhere.10 In
addition, a small but unknown proportion of patients with
seizure disorder were receiving traditional Chinese medicine.
We incidentally noted a few patients taking herbal medicine
monotherapy for their seizure disorders. A study in Taiwan
showed that about 16% of patients with seizure disorders
took herbal medicine as an “add-on” therapy, in addition to
antiepileptic drugs.30 Other cases omitted from our study
may have included individuals unaware of their epilepsy
and not receiving medical care, as well as those who may
not want to seek medical attention due to concern about
possible prejudices towards people with epilepsy.31
There were 475 900 adults aged 15 years or older living
in the HKW region at the time of the study. Based on our
data, the point prevalence of active epilepsy in the present
study is 1.54 per 1000. Even taking into account the possi-
bility of 7% underreporting of epilepsy due to using medical
record as a source of information as suggested by Haerer et
al,22 our figure is low compared with other reported pre-
valence rates worldwide. This could reflect inadequate
enrolment of patients with seizure disorder at the prevalence
date, and thus, the derived prevalence may underestimate
the true prevalence rate.
To date, only a few epidemiological surveys of epilepsy
among Chinese populations are available.26,27 Li et al26 re-
ported a lifetime prevalence of 4.4 cases per 1000 in the urban
areas of China. Considering the epidemiological data of
epilepsy throughout the world, prevalence rates were
intermediate in white population studies in the US and
Europe and were low in the Asian population, based on other
studies performed in India and Japan.23,32,33 Although the low
estimated prevalence in our study could be due to under-
reporting as a consequence of denial of illness secondary to
the psychosocial stress associated with epilepsy,31,34,35 two
other Hong Kong–based epidemiological studies reported
a similar prevalence rate for epilepsy at 0.45 and 1.52 per
1000, respectively.28,29 The projected number of patients with
epilepsy in Hong Kong based on these rates would be 3150
and 10 780, respectively, for a territory-wide population of
7 million.36
The aetiological classification of epilepsy in this study
revealed idiopathic epilepsy in 38.7% of patients, crypto-
genic epilepsy in 13.6%, and remote symptomatic epilepsy
in 38.7%. These proportions are comparable with other
studies reported worldwide. However, they differ from the
Hong Kong data reported by Ng et al29 who found only
3.9% of cases had idiopathic epilepsy, 59.9% cryptogenic
epilepsy, and 35.1% remote symptomatic epilepsy. In the
current study, we were able to classify 91% of epilepsies
and syndromes according to current ILAE classification
system. The proportions of patients with partial seizures and
generalised seizures were 55.4% and 38.8%, respectively.
The most frequent seizure subtypes were partial seizures
with secondary generalisation, which was followed by
complex partial seizure and generalised tonic-clonic seizure.
There was no significant difference seen between the sexes.
There are discrepancies between the current study and the
data reported by Ng et al,29 who found 80.7% of patients
had generalised tonic-clonic seizures, and 28.3% of patients
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complex partial seizures. Similar observations were made
by Li et al26 in the case series reported in 1985. The
differences could possibly reflect differences in the design
of questionnaires used, the extensiveness of diagnostic
evaluation, advances in diagnostic tests and genetic
knowledge, and inappropriate application of the ILAE
classification and misclassification of non-epileptic patients
as having a generalised seizure disorder. Nevertheless,
whether partial or generalised seizures predominate in
epilepsy remains controversial.37-41 The trend with respect
to the predominance of partial seizure in the adult patients
reported in this study was also observed in the epidemio-
logical data reported by Kwong et al.28 They found that 64%
of children aged 5 years or less suffered from generalised
seizures compared with 41% of the older group studied.
Epidemiological findings from four studies conducted in
China are summarised in Table 4.
Identification of familial epilepsy cases is crucial to
further molecular genetic research into epilepsy. The QMH
epilepsy clinic actively searched for familial cases of
epilepsy. Interestingly, our data showed a huge discrepancy
from western data with respect to idiopathic generalised
epilepsy, in particular, JME and CAE, the two most com-
mon idiopathic forms of epilepsy with a definite genetic
basis.42,43 It has been estimated that JME accounts for 10%
to 30% of all epilepsies.44 Childhood absence epilepsies with
or without grand mal account for another 5% to 15% of all
epilepsies.8,45 Our observations are consistent with those
reported by Kwong et al,28 who identified three cases of
CAE and one case of JME from a cohort of 309 paediatric
patients. In the present study, only five patients with JME
and seven patients with CAE were identified. A positive
family history could be found in only two patients with JME
and five patients with CAE. Considering the study population
as a whole, this means 0.68% and 0.95% of all subjects
with active epilepsy had JME and CAE, respectively. Among
the 31 patients with a positive family history, the most
prevalent form of idiopathic epilepsy syndrome was
idiopathic generalised epilepsy, with generalised tonic-
clonic seizure (48.38%). This major discrepancy between
western data and local data could possibly reflect ethnic
differences in genetic constitution.36
Conclusion
The epidemiological data for patients with active epilepsy
resident within a defined geographic area of Hong Kong
was analysed. The prevalence rate of active epilepsy in this
Chinese, adult population was low compared with that
reported in other developed countries. A larger, population-
based, epidemiological study is indicated to confirm the
findings of this study.
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